Breaking News

HHS to seek more input on drug price negotiations; doctors group urges FDA to convene panel on Alzheimer's drug

 

Pharmalot Ed Silverman

STAT+: HHS will seek more input on its new Medicare drug price negotiations

By Rachel Cohrs

Chris Carlson/AP

HHS laid out a detailed timeline of when the public can weigh on on the agency’s new Medicare drug price negotiation program.

Read More

STAT+: Physicians group urges FDA to convene expert panel before finally approving an Alzheimer's drug

By Ed Silverman

Adobe

“Right now, I don’t know, as a clinician, if I would recommend this to my patients,” said Reshma Ramachandran of Doctors for America.

Read More

Opinion: FTC's proposed ban on noncompete agreements could be a game changer for some physicians

By Jeff Goldsmith

Photo by Mario Tama/Getty Images

A federal proposal to outlaw noncompete agreements would make it easier for physicians to switch from employment to private practice.

Read More

Opinion: Another Ebola outbreak, another missed opportunity for preparedness

By Swati Gupta

Hajarah Nalwadda/AP

The world needs a stockpile of candidate vaccines that are available to be tested during outbreaks of Ebola, Nipah, and other diseases.

Read More

Wednesday, January 11, 2023

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2023, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments